Imaging in Heart Failure with Preserved Ejection Fraction: A Multimodality Imaging Point of View-Reference-Cited by-同舟云学术

Imaging in Heart Failure with Preserved Ejection Fraction: A Multimodality Imaging Point of View

Published:2023-04-04 Issue: Volume:9 Page:
ISSN:2057-7559
Container-title:Cardiac Failure Review
language:en
Short-container-title:Card Fail Rev

Author:

Ünlü Serkan¹^ORCID,Özden Özge²^ORCID,Çelik Ahmet³^ORCID

Affiliation:

1. Department of Cardiology, Gazi University, Ankara, Turkey

2. Cardiology Department, Memorial Bahçelievler Hospital, Istanbul, Turkey

3. Department of Cardiology, Mersin University, Mersin, Turkey

Abstract

Heart failure with preserved ejection fraction (HFpEF) is an important global health problem. Despite increased prevalence due to improved diagnostic options, limited improvement has been achieved in cardiac outcomes. HFpEF is an extremely complex syndrome and multimodality imaging is important for diagnosis, identifying its different phenotypes and determining prognosis. Evaluation of left ventricular filling pressures using echocardiographic diastolic function parameters is the first step of imaging in clinical practice. The role of echocardiography is becoming more popular and with the recent developments in deformation imaging, cardiac MRI is extremely important as it can provide tissue characterisation, identify fibrosis and optimal volume measurements of cardiac chambers. Nuclear imaging methods can also be used in the diagnosis of specific diseases, such as cardiac amyloidosis.

Publisher

Radcliffe Media Media Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference98 articles.

1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368; PMID: 34447992.

2. Pieske B, Tschöpe C, De Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297–317. https://doi.org/10.1093/eurheartj/ehz641; PMID: 31504452.

3. Smiseth OA, Morris DA, Cardim N, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2022;23:e34–61. https://doi.org/10.1093/ehjci/jeab154; PMID: 34729586.

4. Sorrentino R, Esposito R, Santoro C, et al. Practical impact of new diastolic recommendations on noninvasive estimation of left ventricular diastolic function and filling pressures. J Am Soc Echocardiogr 2020;33:171–81. https://doi.org/10.1016/j.echo.2019.08.013; PMID: 31619369.

5. Obokata M, Reddy YNV, Borlaug BA. The role of echocardiography in heart failure with preserved ejection fraction: what do we want from imaging? Heart Fail Clin 2019;15:241–56. https://doi.org/10.1016/j.hfc.2018.12.004; PMID: 30832815.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left Atrial Coupling Index Predicts Heart Failure in Patients with End Stage Renal Disease;Medicina;2024-07-24

2. Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction;Reviews in Cardiovascular Medicine;2024-07-23

3. Challenges in Echocardiography for the Diagnosis and Prognosis of Non-Ischemic Hypertensive Heart Disease;Journal of Clinical Medicine;2024-05-04

4. Apoptosis and heart failure: The role of non-coding RNAs and exosomal non-coding RNAs;Pathology - Research and Practice;2023-08